Cargando…

Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease

Previously, we showed that sodium/glucose cotransporter 1 (SGLT1) participates in vascular cognitive impairment in small vessel disease. We hypothesized that SGLT1 inhibitors can improve the small vessel disease induced‐vascular cognitive impairment. We examined the effects of mizagliflozin, a selec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishida, Nanae, Saito, Maki, Sato, Sachiko, Tezuka, Yu, Sanbe, Atsushi, Taira, Eiichi, Hirose, Masamichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480397/ https://www.ncbi.nlm.nih.gov/pubmed/34586752 http://dx.doi.org/10.1002/prp2.869

Ejemplares similares

FRI605 Inhibition Of Intestinal SGLT1 With Mizagliflozin For The Treatment Of Post-bariatric Hypoglycemia
por: Margaret Lawler, Helen, et al.
Publicado: (2023)

Effect of Mizagliflozin on Postprandial Plasma Glucose in Patients With Functional Constipation
por: Fukudo, Shin, et al.
Publicado: (2019)

Cardiac Overexpression of Constitutively Active Galpha q Causes Angiotensin II Type1 Receptor Activation, Leading to Progressive Heart Failure and Ventricular Arrhythmias in Transgenic Mice
por: Matsushita, Naoko, et al.
Publicado: (2014)

Euphausia pacifica (North Pacific Krill): Review of Chemical Features and Potential Benefits of 8-HEPE against Metabolic Syndrome, Dyslipidemia, NAFLD, and Atherosclerosis
por: Ishida, Nanae, et al.
Publicado: (2021)

Regulation of Neurite Growth by Inorganic Pyrophosphatase 1 via JNK Dephosphorylation
por: Tezuka, Yu, et al.
Publicado: (2013)

The Role of SGLT2 Inhibitors in Vascular Aging
por: Liu, Le, et al.
Publicado: (2021)

Decreased parenchymal arteriolar tone uncouples vessel-to-neuronal communication in a mouse model of vascular cognitive impairment
por: Kim, Ki Jung, et al.
Publicado: (2021)

Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption
por: Unno, Keiko, et al.
Publicado: (2023)

The Intersection of SGLT2 Inhibitors, Cognitive Impairment, and CKD
por: Noel, J. Ariana, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment
por: Samukawa, Yoshishige, et al.
Publicado: (2018)

The cardiopharyngeal mesoderm contributes to lymphatic vessel development in mouse
por: Maruyama, Kazuaki, et al.
Publicado: (2022)

Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease(2)
por: Wallin, Anders, et al.
Publicado: (2018)

Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management
por: Zanon Zotin, Maria Clara, et al.
Publicado: (2021)

Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases?
por: Nomiyama, Takashi
Publicado: (2020)

The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease
por: Ohara, Ken, et al.
Publicado: (2020)

Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells
por: Maki, Toshinobu, et al.
Publicado: (2019)

Nicorandil Prevents Gα(q)-Induced Progressive Heart Failure and Ventricular Arrhythmias in Transgenic Mice
por: Hirose, Masamichi, et al.
Publicado: (2012)

Postischemic Anhedonia Associated with Neurodegenerative Changes in the Hippocampal Dentate Gyrus of Rats
por: Kasahara, Jiro, et al.
Publicado: (2016)

Zika virus impairs the development of blood vessels in a mouse model of congenital infection
por: Garcez, P. P., et al.
Publicado: (2018)

Identification of Inter-Organ Vascular Network: Vessels Bridging between Organs
por: Omae, Madoka, et al.
Publicado: (2013)

Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types
por: He, Liqun, et al.
Publicado: (2018)

The Role of Transcortical Vessels in Diaphyseal Vascularity
por: Asghar, Adil
Publicado: (2019)

SGLT2 and cancer
por: Wright, Ernest M.
Publicado: (2020)

Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report
por: Wallin, A., et al.
Publicado: (2017)

Modified cerebral small vessel disease score is associated with vascular cognitive impairment after lacunar stroke
por: Zhi, Nan, et al.
Publicado: (2021)

EP3 Receptor Deficiency Improves Vascular Remodeling and Cognitive Impairment in Cerebral Small Vessel Disease
por: Liu, Na, et al.
Publicado: (2022)

Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2
por: Oranje, Paul, et al.
Publicado: (2019)

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
por: West, James, et al.
Publicado: (2021)

SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
por: Igarashi, Hiroyuki, et al.
Publicado: (2023)

Impaired Glymphatic Function and Pulsation Alterations in a Mouse Model of Vascular Cognitive Impairment
por: Li, Mosi, et al.
Publicado: (2022)

SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice
por: Spatola, Leonardo, et al.
Publicado: (2017)

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
por: Ghezzi, Chiara, et al.
Publicado: (2018)

Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
por: Sayour, Alex Ali, et al.
Publicado: (2021)

The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma
por: Jojima, Teruo, et al.
Publicado: (2019)

Influenza A Virus Causes Histopathological Changes and Impairment in Functional Activity of Blood Vessels in Different Vascular Beds
por: Marchenko, Vladimir, et al.
Publicado: (2022)

Small Vessel Disease and Subcortical Vascular Dementia
por: Kalaria, Raj N., et al.
Publicado: (2006)

Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia
por: Uemura, Maiko T., et al.
Publicado: (2020)

Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages
por: Koike, Masao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_88un4h2tm27phdk94na0grcd2r